Different Clinical Presentations of Human Rhinovirus Species Infection in Children and Adults in Mexico

Arturo Galindo-Fraga, Paola Del Carmen Guerra-de-Blas, Ana M Ortega-Villa, Allyson Mateja, Jesus Arturo Ruiz Quiñones, Pilar Ramos Cervantes, Fernando Ledesma Barrientos, Ana A Ortiz-Hernández, Beatriz Llamosas-Gallardo, Alejandra Ramírez-Venegas, Rafael Valdéz Vázquez, Daniel Noyola Chepitel, Sarbelio Moreno-Espinosa, John H Powers, M Lourdes Guerrero, Guillermo M Ruiz-Palacios, John H Beigel, Mexican Emerging Infectious Diseases Network, Arturo Galindo-Fraga, Paola Del Carmen Guerra-de-Blas, Ana M Ortega-Villa, Allyson Mateja, Jesus Arturo Ruiz Quiñones, Pilar Ramos Cervantes, Fernando Ledesma Barrientos, Ana A Ortiz-Hernández, Beatriz Llamosas-Gallardo, Alejandra Ramírez-Venegas, Rafael Valdéz Vázquez, Daniel Noyola Chepitel, Sarbelio Moreno-Espinosa, John H Powers, M Lourdes Guerrero, Guillermo M Ruiz-Palacios, John H Beigel, Mexican Emerging Infectious Diseases Network

Abstract

Background: Human rhinoviruses (HRVs) are a common cause of influenza-like illness, with the ability to infect the upper and lower respiratory tracts. In this study we aim to describe the clinical and molecular features of HRV infection in Mexican children and adults.

Methods: We performed a hospital-based, 4-year multicenter prospective observational cohort study of patients with influenza-like illness. Participants who tested positive for HRV were included. We described demographic, clinical, and laboratory characteristics and the association between HRV types, illness severity, and clinical outcomes.

Results: Of the 5662 subjects recruited, 1473 (26%) had HRV; of those, 988 (67.1%) were adults (≥18 years) and 485 (32.9%) were children. One hundred sixty-seven (11.33%) samples were sequenced; 101 (60.5%) were rhinovirus species A (HRV-A), 22 (13.2%) were rhinovirus species B (HRV-B), and 44 (26.3%) were rhinovirus species C (HRV-C). Among children and adults, 30.5% and 23.5%, respectively, were hospitalized (non-intensive care unit [ICU]). The odds of HRV-C are higher than HRV-A for participants in the ICU (compared to outpatient) and when platelets, lymphocytes, white blood cells, and lactate dehydrogenase are increased. The odds of HRV-C are higher than HRV-A and HRV-B with shortness of breath. The odds of HRV-A are higher than HRV-B, and the odds of HRV-B are higher than HRV-C, when mild symptoms like muscle ache and headache occur.

Conclusions: Rhinoviruses are a common cause of influenza-like illness. It is necessary to improve the surveillance, testing, and species identification for these viruses to understand different clinical presentations and risk factors associated with worse outcomes. Clinical Trials Registration. NCT01418287.

Keywords: HRV species; clinical presentation; influenza-like illness; rhinovirus; severity.

© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Figures

Figure 1.
Figure 1.
Odds ratios and associated 95% confidence intervals for the rhinovirus types for each characteristic in a univariate model. Characteristics below the solid black line are laboratory parameters, body mass index, and age. Abbreviations: BMI, body mass index; CPK, creatine phosphokinase; CRP, C-reactive protein; F, female; HRV, human rhinovirus; ICU, intensive care unit; LDH, lactate dehydrogenase; M, male; WBC, white blood cell.
Figure 2.
Figure 2.
Viral load (copies/mL) by human rhinovirus (HRV) type and hospitalization status at baseline. No statistically significant differences associated with HRV type (P  = .243) (A) or hospitalization status (P  = .318) (B). P values are from a Kruskal-Wallis test for comparison between groups. Abbreviations: HRV, human rhinovirus; ICU, intensive care unit.
Figure 3.
Figure 3.
Phylogenetic analysis of human rhinovirus (HRV). The 558-bp fragment VP4/VP2 genomic region was analyzed by MEGA version 6 software. Associations between samples were done by the neighbor-joining method with bootstrap analysis of 1000 replicates for each HRV A, B, and C type.

References

    1. Aponte FE, Taboada B, Espinoza MA, et al. . Rhinovirus is an important pathogen in upper and lower respiratory tract infections in Mexican children. Virol J 2015; 12:31.
    1. Souty C, Masse S, Valette M, et al. . Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care. Clin Microbiol Infect 2019; 25:1147–53.
    1. Drysdale SB, Mejias A, Ramilo O. Rhinovirus—not just the common cold. J Infect 2017; 74(Suppl 1):S41–6.
    1. Lee WM, LemanskeRF, Jr, Evans MD, et al. . Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 2012; 186:886–91.
    1. Nguyen DNT, Mai LQ, Bryant JE, et al. . Epidemiology and etiology of influenza-like-illness in households in Vietnam: it’s not all about the kids!. J Clin Virol 2016; 82:126–32.
    1. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003; 163:487–94.
    1. Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO. Allergic rhinitis and the common cold—high cost to society. Allergy 2010; 65:776–83.
    1. Hershenson MB. Rhinovirus-induced exacerbations of asthma and COPD. Scientifica (Cairo) 2013; 2013:405876.
    1. To KKW, Yip CCY, Yuen KY. Rhinovirus—from bench to bedside. J Formos Med Assoc 2017; 116:496–504.
    1. Ljubin-Sternak S, Meštrović T, Ivković-Jureković I, et al. . The emerging role of rhinoviruses in lower respiratory tract infections in children—clinical and molecular epidemiological study from Croatia, 2017–2019. Front Microbiol 2019; 10:2737.
    1. Hung IF, Zhang AJ, To KK, et al. . Unexpectedly higher morbidity and mortality of hospitalized elderly patients associated with rhinovirus compared with influenza virus respiratory tract infection. Int J Mol Sci 2017; 18:259.
    1. Vandini S, Biagi C, Fischer M, Lanari M. Impact of rhinovirus infections in children. Viruses 2019; 11:521.
    1. Chu HY, Englund JA, Strelitz B, et al. . Rhinovirus disease in children seeking care in a tertiary pediatric emergency department. J Pediatr Infect Dis Soc 2016; 5:29–38.
    1. Chen W-J, Arnold JC, Fairchok MP, et al. . Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: rhinovirus among adults and children. J Clin Virol 2015; 64:74–82.
    1. Cox DW, Khoo SK, Zhang G, et al. . Rhinovirus is the most common virus and rhinovirus-C is the most common species in paediatric intensive care respiratory admissions. Eur Respir J 2018; 52:1800207.
    1. Calvo C, Casas I, García-García ML, et al. . Role of rhinovirus C respiratory infections in sick and healthy children in Spain. Pediatr Infect Dis J 2010; 29:717–20.
    1. de Almeida MB, Zerbinati RM, Tateno AF, et al. . Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. Emerg Infect Dis 2010; 16:996–9.
    1. Galindo-Fraga A, Ortiz-Hernández AA, Ramírez-Venegas A, et al. . Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City. Int J Infect Dis 2013; 17:e510–7.
    1. World Health Organization . WHO surveillance case definitions for ILI and SARI. . Accessed 16 April 2021.
    1. Jin Y, Yuan XH, Xie ZP, et al. . Prevalence and clinical characterization of a newly identified human rhinovirus C species in children with acute respiratory tract infections. J Clin Microbiol 2009; 47:2895–900.
    1. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 2013; 30:2725–9.
    1. Ng KT, Chook JB, Oong XY, et al. . Performance of a TaqMan assay for improved detection and quantification of human rhinovirus viral load. Sci Rep 2016; 6:34855.
    1. García J, Espejo V, Nelson M, et al. . Human rhinoviruses and enteroviruses in influenza-like illness in Latin America. Virol J 2013; 10:305.
    1. Bizot E, Bousquet A, Charpié M, et al. . Rhinovirus: a narrative review on its genetic characteristics, pediatric clinical presentations, and pathogenesis. Front Pediatr 2021; 9:643219.
    1. Chiu YT, Tien N, Lin HC, et al. . Detection of respiratory pathogens by application of multiplex PCR panel during early period of COVID-19 pandemic in a tertiary hospital in Central Taiwan [manuscript published online ahead of print 6 October 2021]. J Microbiol Immunol Infect 2021. doi:10.1016/j.jmii.2021.09.011.
    1. Golke P, Hönemann M, Bergs S, Liebert UG. Human rhinoviruses in adult patients in a tertiary care hospital in Germany: molecular epidemiology and clinical significance. Viruses 2021; 13:2027.
    1. Fica A, Dabanch J, Andrade W, et al. . Clinical relevance of rhinovirus infections among adult hospitalized patients. Braz J Infect Dis 2015; 19:118–24.
    1. Adam DC, Chen X, Scotch M, MacIntyre CR, Dwyer D, Kok J. The molecular epidemiology and clinical phylogenetics of rhinoviruses among paediatric cases in Sydney, Australia. Int J Infect Dis 2021; 110:69–74.
    1. McCulloch DJ, Sears MH, Jacob JT, et al. . Severity of rhinovirus infection in hospitalized adults is unrelated to genotype. Am J Clin Pathol 2014; 142:165–72.
    1. Li W, Yu B, Zhou J, et al. . Genetic diversity and epidemiology of human rhinovirus among children with severe acute respiratory tract infection in Guangzhou, China. Virol J 2021; 18:174.
    1. Kim JH, Jang JY, Jang YJ. Human rhinovirus serotypes induces different immune responses. Virol J 2021; 18:232.
    1. Kirchberger S, Majdic O, Stöckl J. Modulation of the immune system by human rhinoviruses. Int Arch Allergy Immunol 2007; 142:1–10.
    1. Megremis S, Niespodziana K, Cabauatan C, et al. . Rhinovirus species-specific antibodies differentially reflect clinical outcomes in health and asthma. Am J Respir Crit Care Med 2018; 198:1490–9.
    1. Pang LL, Yuan XH, Shao CS, et al. . The suppression of innate immune response by human rhinovirus C. Biochem Biophys Res Commun 2017; 490:22–8.
    1. Esneau C, Duff AC, Bartlett NW. Understanding rhinovirus circulation and impact on illness. Viruses 2022; 14:141.
    1. Kiseleva I, Ksenafontov A. COVID-19 shuts doors to flu but keeps them open to rhinoviruses. Biology (Basel) 2021; 10:733.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅